// Research library
Latest Studies.
The papers behind each peptide in the portfolio, read the same way we read a Certificate of Analysis: design, model, numbers and limits. Every entry links to its source.
BPC-157: Faster Tendon-To-Bone Healing In Rat Models
In a rat Achilles detachment model, systemic BPC-157 improved functional, biomechanical and histological healing endpoints over 21 days, and countered the aggravating effect of a corticosteroid.
Thymosin β4 And Cardiac Repair: The Nature 2004 Model
Bock-Marquette and colleagues showed that thymosin β4 forms a complex with PINCH and integrin-linked kinase, activates Akt, and improved early cardiomyocyte survival and cardiac function after coronary ligation in mice.
CJC-1295: One Dose, IGF-1 Elevated For Over A Week
In two randomized, placebo-controlled ascending-dose trials in healthy adults, a single subcutaneous dose of CJC-1295 raised growth hormone for six days or more and IGF-1 for nine to eleven days.
GHK-Cu Vs Vitamin C: 70% Against 50% In 12 Weeks
A small clinical study presented at the American Academy of Dermatology compared a copper-peptide facial cream with a vitamin C cream over twelve weeks, reporting increased collagen production in 70% of the peptide group against 50% for vitamin C.
Ipamorelin, 1998: GH Up, Cortisol And Prolactin Unchanged
The paper that introduced ipamorelin showed a pentapeptide releasing growth hormone with the potency of GHRP-6 but without the ACTH, cortisol or prolactin rise, even at doses more than 200 times the effective dose.
BPC-157 And Angiogenesis: One Lab Behind Most Of The Data
In cell culture BPC-157 had no direct angiogenic effect. In injured rat muscle and tendon it up-regulated VEGF and produced a more organized vascular response, a pattern the Zagreb group describes as angiomodulation rather than angiogenesis.
Nothing matches this filter.
How we grade evidence
Three letters, read before the headline.
Controlled human outcomes
Randomized trials or regulatory approvals with clinical endpoints.
Limited human data
Phase 1 or 2 studies, topical work, small samples or congress abstracts.
Preclinical
Cell, animal or mechanistic work. A hypothesis, not a result in people.
Halor summarizes published research for laboratory context only. Nothing here is medical advice or a claim about the use of any product in humans.